Position in GILD
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$625,635
-$64,246 QoQ
Shares Held
4,952
+0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,279
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Van Cleef Asset Management,Inc holds $14,679,161 across 8 Drug Manufacturers - General names. GILD ranks #6 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,838 | $4,276,346 | |
| 2 | LLY |
ELI LILLY & Co
|
2,762 | $3,312,825 | |
| 3 | MRK |
Merck & Co., Inc.
|
18,933 | $2,432,890 | |
| 4 | ABBV |
AbbVie Inc.
|
7,570 | $1,904,914 | |
| 5 | PFE |
Pfizer Inc
|
44,347 | $1,067,875 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
4,952 | $625,635 | |
| 7 | AMGN |
Amgen Inc
|
1,572 | $569,252 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,494 | $489,424 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $625,635 | 4,952 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $689,881 | 4,950 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $673,842 | 5,490 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $609,390 | 5,490 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $608,676 | 5,490 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $615,154 | 5,490 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $550,063 | 5,955 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $525,676 | 6,270 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $519,720 | 7,575 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $722,611 | 9,865 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $827,517 | 10,215 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $780,500 | 10,415 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $859,715 | 11,155 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $939,635 | 11,325 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,277,437 | 73,121 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,581,284 | 74,263 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,670,919 | 75,569 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,576,877 | 76,987 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,644,265 | 77,734 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,555,380 | 79,533 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,508,662 | 79,998 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,450,118 | 84,328 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,000,630 | 85,833 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $5,631,935 | 89,127 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $6,933,217 | 90,112 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $6,755,612 | 90,364 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||